Reporting of adverse events ONLY

Patients should always seek the advice of a doctor or pharmacist in case of adverse events.

If you wish to report an adverse event to ELC Group s.r.o., please find the contact information below:

+420 224 910 672

(from 09.00-17.30 CET)

+420 226 251 459

(non-stop 24/7)

To contact us about any other issue please call:

+420 22 491 0000or our regional offices.

Hlášení nežádoucích príhod

Pacienti by meli vždy požádat o radu svého lékare nebo lékárníka v prípade výskytu nežádoucích príhod.

Pokud chcete nahlásit nežádoucí príhodu spolecnosti ELC Group s r.o., prosím využijte kontaktních údaju níže:

+420 224 910 672

(09.00-17.30 CET)

+420 226 251 459

(non-stop 24/7)

Pro záležitosti, které se netýkaji farmakovigilance, kontaktujte prosím recepci:

+420 22 491 0000 nebo naše další pobočky.

EU Clinical Strategy

Date: 03, March, 2021

Time: 10:00 CET

Price: Free of charge

On Wednesday 3rd March 2021, at 10:00 CET (Central European Time, UTC+ 1), ELC will be hosting a webinar providing an overview on the EU Clinical Strategy- How to map an optimal pathway in your product’s clinical development.

The presenters will be Amit Salvi, Senior Expert for Pre-clinical, Clinical and Medical Writing, and Thibaut Mouly, Business Development Senior Executive.

We are going to take you through the following topics:

  1. Non-Clinical and Clinical Strategy
  2. EU Scientific Advance Meeting: Support for Non-Clinical and Clinical development
  3. Clinical Study Management
  4. Consolidation and presentation of Non-Clinical and Clinical Data in a regulatory dossier
  5. Q&A

Please note that the number of participants is limited.

To register, click here